Study of WD-1603 dosing intervals in healthy adults
This study tests how a new medicine (WD-1603) is processed by the body when taken before meals at different time intervals. It is for healthy volunteers to help determine the best dosing schedule.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old and in good general health.
- You weigh at least 50 kg (for men) or 45 kg (for women), with a BMI between 18 and 27.
- You have no major medical conditions, including heart disease, diabetes, asthma, glaucoma, or cancer.
- You are not regularly taking any medications (including supplements or herbal products) and are not a heavy smoker.
- You agree to avoid pregnancy or donating sperm/eggs during the study and for 3 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.
This study tests how three drugs (DWP16001, DWC202407, and DWC202408) interact when taken together in healthy adults. It helps make sure the drugs are safe and that there are no unexpected side effects when combined.
This trial tests a new medicine, WD-910, to see if it's safe and how the body processes it. It's for healthy adults who can swallow pills.
This study tests a new oral medication called EC5026 for Parkinson's disease. It aims to see if the drug is safe and if it might help control symptoms when added to your current levodopa treatment.
This study tests an investigational drug called LBT-3627 to see if it is safe and how the body processes it. It includes healthy volunteers and people with Parkinson's disease, and may help determine if the drug could be a future treatment.
Hear when a new Healhty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.